TrialDrugs & aging2003

Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE).

Mark Nelson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.